Advertisement
Advertisement
U.S. Markets open in 1 hr 50 mins
Advertisement
Advertisement
Advertisement
Advertisement

Biotricity, Inc. (BTCY)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.2300+0.0100 (+0.31%)
At close: 04:00PM EST
3.2600 +0.03 (+0.93%)
Pre-Market: 07:26AM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close3.2200
Open3.1600
Bid3.2000 x 1000
Ask3.3000 x 1400
Day's Range3.0100 - 3.2600
52 Week Range1.1300 - 5.3000
Volume305,741
Avg. Volume423,570
Market Cap158.685M
Beta (5Y Monthly)2.22
PE Ratio (TTM)N/A
EPS (TTM)-0.6780
Earnings DateFeb 09, 2022 - Feb 14, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.67
  • ACCESSWIRE

    Biotricity Expands Distribution of New Bioheart Device on Amazon.com

    New Heart Monitoring Solution Delivers Personalized Heart Health Insights Directly to Your SmartphoneNow Easy to Buy and Use: No Prescription Needed for Advanced Heart and Lifestyle SolutionREDWOOD CITY, CA / ACCESSWIRE / December 28, 2021 /Biotricity Inc. (NASDAQ:BTCY) a modern medical technology company delivering innovative, remote biometric monitoring solutions, today announced it has expanded the distribution of its new Bioheart heart monitor system, a direct-to-consumer device that offers

  • ACCESSWIRE

    Biotricity Completes $12 Million Non-Dilutive Debt Financing

    Capital infusion to finance inventory and annual recurring revenue subscriptions replaces expiring debt with more favorable terms5-year term deal strengthens balance sheet, positions company for multiple new product launches in 2022 REDWOOD CITY, CA / ACCESSWIRE / December 27, 2021 /Biotricity Inc. (NASDAQ:BTCY) a modern medical technology company delivering innovative, remote biometric monitoring solutions, today announced the successful completion of a $12 million non-convertible debt financin

  • ACCESSWIRE

    Biotricity, a Leader in Remote Cardiac Health Monitoring Solutions, Issues Company Roadmap in 2021 Shareholder Letter

    The Company believes that it is "well-positioned for 2022."Letter highlights milestones, products roadmap, growth strategy and 2022 goalsREDWOOD CITY, CA / ACCESSWIRE / December 7, 2021 / Biotricity, Inc.

Advertisement
Advertisement